Vannice, Kirsten S.
Hills, Susan L.
Schwartz, Lauren M.
Barrett, Alan D.
Heffelfinger, James
Hombach, Joachim
Letson, G. William
Solomon, Tom
Marfin, Anthony A.
Anderson, Katie
Fischer, Marc
Fox, Kim
Jacobson, Julie
Liyanage, Jayantha
Marks, Florian
Ogbuanu, Ike
Tharmaphornpilas, Piyanit
,
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Article History
Received: 27 July 2020
Accepted: 15 April 2021
First Online: 15 June 2021
Competing interests
: No conflicts of interest: G.W.L., J.M.H., J.H., S.H., L.M.S., K.V., A.A.M. T.S. is supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (Grant No. IS-HPU-1112-10117), NIHR Global Health Research Group on Brain Infections (No. 17/63/110), and the European Union’s Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network), grant agreement No. 734584. A.D.T.B. is Editor in Chief of <i>npj Vaccines</i>.